Telehealth startups have proliferated across Europe and the UK, and a significant number have run into the same problem: a fragmented system that makes scaling genuinely difficult. The GCC largely takes care of that fragmentation, but that does not make it easy. Dubai’s licensing and compliance framework touches legal entity structure, clinical staffing, patient consent, data handling and ongoing reporting. For a founder used to thinking of telehealth as primarily a software problem, that is worth knowing before the product is built.
The starting point is the licence itself. Any health facility or standalone telehealth platform needs to be licensed by the Dubai Health Authority (DHA), with specific approval to conduct telehealth activities. No licence, no service. That approval process is also where the DHA begins to look at everything else.
Clinical staffing is the next consideration, and it is one that catches some founders off guard. Telehealth in Dubai must be physician-led, and every clinician on the platform, whether a doctor, nurse or allied health professional, must hold a DHA licence and be properly privileged under DHA regulations. The platform is only as licensed as the people on it.
Data handling is woven into the licensing logic rather than treated as a separate compliance question. The DHA standard references Federal Law No. 2 of 2019 on health information and communication technology, which means decisions about where patient records sit and how information moves need to be made before the application goes in, not after.
The framework does not end at launch. Once licensed, facilities have a 24-month grace period to obtain full telehealth accreditation, and from that point are required to report to the DHA quarterly on defined performance indicators.
For anyone building toward a Dubai telehealth licence: legal entity, facility or platform licence, clinician licensing and privileging, service scope, patient consent process, data storage architecture, claims handling, quarterly reporting. In that order.